In short
Act 79-2020, known as the Gabriela Nicole Correa Act, requires every insurer or health insurance organization offering individual or group plans in Puerto Rico to have available coverage that mandatorily includes the treatments, medications and diagnostic tests included in the National Comprehensive Cancer Network (NCCN) guidelines or approved by the FDA, as well as those needed to treat and minimize their adverse effects — meaning also the drugs given alongside chemotherapy against nausea, allergies, inflammation and immune system weakening. The piece most used day to day is the clock: every health plan, individual or group, must issue its approval or denial of those medications, treatments and diagnostic tests within 24 to 72 hours of receiving the request, or within 24 hours if the case is marked urgent or expedited. And the law closes the door on silence: if it fails to issue its determination within that term, they shall be deemed approved. Separately, Act 107-2012 requires a plan that covers chemotherapy to cover it in its various administration methods — intravenous, oral, injectable or intrathecal — per the order of the specialist physician or oncologist.
What is it?
These are two short laws read together. Act 79-2020 sets what must be covered and how fast they must answer; Act 107-2012 keeps the route by which chemotherapy is administered from deciding whether it is covered. Act 79-2020 sits above the insurance codes: where it conflicts with the Puerto Rico Insurance Code or the Health Insurance Code, it prevails. And it applies without exclusion to all insurers, third parties they contract, administrators, benefit managers and those contracting with ASES — meaning it also reaches the Government Health Plan.
Who can do it?
Every covered or insured person under an individual or group health plan in Puerto Rico who is in the process of cancer diagnosis or treatment. The law defines cancer diagnosis early: it is the process of identifying and assessing a finding, once a lump or another sign or symptom has been found, using the diagnostic tests contained in the NCCN guidelines. That is, the deadlines do not start once cancer is confirmed, but from the tests that seek to confirm it. An honest limit: the law applies prospectively and does not impair contractual obligations predating it; contracts signed earlier had to comply upon expiration, extension or renewal.
Requirements
- That the medication, treatment or diagnostic test be in the National Comprehensive Cancer Network (NCCN) guidelines or approved by the FDA.Verified against the official source
- That the plan has received a request: the 24 to 72 hour terms run from receipt of the request.Verified against the official source
- For designating the oncologist as primary care provider, that the health professional consents to the designation.Verified against the official source
Documents you need
Cost
Step by step
Step 1: Mark the case urgent if it is
The general term is 24 to 72 hours from receipt of the request, but drops to 24 hours when the case is marked urgent or expedited. Whoever submits the request marks it, so it is worth discussing with your physician or oncologist before they send it, not after the clock starts.
Step 2: Write down the date and time the plan received the request
The whole article depends on that moment: the term runs from receipt of the request. Ask the medical office for the acknowledgment of receipt, the reference number or the confirmed fax. Without that date you cannot claim the term expired or that it was automatically approved.
Step 3: If the term expires, claim the automatic approval
Article 6 says it without conditions: if the plan fails to issue its determination within that term, the medications, treatments and/or diagnostic tests shall be deemed approved by it. It is not that you get a better appeal; it is that the law deems approved what the plan left unanswered. Put it in writing to the plan, with the request’s receipt date and the article citation.
Step 4: If the problem is the administration route, cite Act 107-2012
A health benefit plan that provides coverage for cancer chemotherapy treatment must equally provide coverage of chemotherapy in its various administration methods: intravenous, oral, injectable or intrathecal, per the medical order of the specialist physician or oncologist. It applies to insurers and health service organizations, to plans serving Puerto Rico, to any entity contracted to offer health benefits, and to ASES and whoever contracts with it.
Step 5: Ask that your oncologist be your primary care provider
If your plan requires you to designate a primary care provider, Article 7 allows a physician specialized in oncology to be designated in that capacity for cancer patients, as long as that health professional gives consent. The law says the plan may allow it, so start by asking the plan in writing and by confirming the oncologist’s consent.
Step 6: Take the non-compliance to the Patient Advocate
The Office of the Patient Advocate has jurisdiction to intervene in violations of patients’ rights under this law, and may issue a non-compliance report. That report is referred to the Office of the Insurance Commissioner and is sufficient basis for it to start and complete an adjudicative process against the insurer. It may also be referred to ASES, where it is sufficient basis to begin cancelling the insurer’s Government Health Plan contract.
Where to do it
The authorization request is submitted by your physician or oncologist to your health plan or to whoever administers your benefits. The non-compliance claim goes to the Office of the Patient Advocate, which has express jurisdiction under this law. The Office of the Insurance Commissioner is the one that sanctions the insurer, and the law ordered it to amend its regulation to include non-compliance with this law as grounds for license suspension or revocation. If you are on the Government Health Plan, ASES is the third route: a non-compliance report is sufficient basis to begin cancelling the insurer’s contract.
How long it takes
24 to 72 hours from when the plan receives the request, or within 24 hours if the case is marked urgent or expedited. If the plan does not issue its determination within that term, it shall be deemed approved.
Verified against the official source · August 23, 2026
What to do if something goes wrong
Two things are worth saying precisely. First: Act 107-2012’s operative article requires equal COVERAGE across chemotherapy administration routes. The whole discussion of high coinsurance, fourth-tier formulary placement and patient out-of-pocket costs lives in its statement of motives, which explains why the law passed but is not the binding text. So this guide does not promise you that the pill’s copay is identical to the IV’s: it tells you coverage must exist on both routes and that the cost-sharing dispute goes to the Office of the Insurance Commissioner. Second: Act 79-2020 mentions, besides the NCCN guidelines and the FDA, other references the insurer will also use — the "Local Coverage Determinations-LCD from First Coast Service Options", the "Medicare Approved Compendia List", the "National Coverage Determinations Alphabetical Index", the "Milliman Care Guidelines" and ASES internal guidelines. We read none of those and they are not Puerto Rico government sources, so we do not tell you what they contain. What is in the law: nothing in it prohibits an insurer from offering broader coverage than the minimum. And what we also did not read here: Act 275-2012, the Bill of Rights of Cancer Patients and Survivors, whose Article 6 this law amended; the rights in this law are additional to those.
Common mistakes
- Letting the term expire without claiming it: the law deems approved whatever the plan did not answer in 24 to 72 hours.
- Not asking for the request’s acknowledgment of receipt, which is where the term runs from.
- Not marking the case urgent or expedited when it is, which would have dropped the term to 24 hours.
- Believing the mandatory coverage only covers chemotherapy: it includes what is needed to treat and minimize its adverse effects.
- Accepting a denial of the oral version of a treatment the plan covers intravenously.
- Accepting a clause leaving final contract interpretation to the insurer’s discretion, which the law prohibits.
- Thinking the Government Health Plan is outside this: the law applies without exclusion to those contracting with ASES.
Frequently asked questions
How long does the plan have to approve or deny a cancer treatment?
24 to 72 hours from receiving the request, or within 24 hours if the case is marked urgent or expedited. It applies to the medications, treatments and diagnostic tests in the NCCN guidelines or FDA-approved.
What happens if the plan does not answer on time?
Article 6 provides that if the health plan fails to issue its determination within that term, the medications, treatments and/or diagnostic tests shall be deemed approved by it. That is why the request’s receipt date matters so much.
Can the plan cover intravenous chemotherapy but not oral?
Act 107-2012 requires that a plan providing coverage for cancer chemotherapy equally provide it in its various administration methods: intravenous, oral, injectable or intrathecal, per the specialist physician’s or oncologist’s order.
Can my oncologist be my primary care physician?
Per Article 7, every plan requiring designation of a primary care provider may allow a physician specialized in oncology to be designated in that capacity for cancer patients, as long as that professional consents to the designation.
What fine does a non-complying insurer face?
In addition to any other penalty under Puerto Rico law, including the Insurance Code, every insurer and every producer found guilty of violating a provision of this law is subject to a fine of up to $10,000. The law clarifies that two different agencies shall not penalize the same insurer for the same violation.
Official sources
These are the government pages this guide is based on.
- Oficina del Procurador del Paciente (OPP)
Procurador del Paciente
bvirtualogp.pr.gov
- Act 107-2012 — equal coverage of oral and intravenous chemotherapy
OGP
bvirtualogp.pr.gov
- Act 275-2012 — Bill of Rights of Cancer Patients and Survivors
OGP
bvirtualogp.pr.gov
- File your claim — Patient Advocate
OPP
www.opp.pr.gov
- Office of the Insurance Commissioner
OCS
ocs.pr.gov
Last verified
August 23, 2026
MiPRFácil is an independent informational website and is not affiliated with, endorsed by, or operated by the Government of Puerto Rico or any government agency.
MiPRFácil does not submit applications on your behalf.
Was this guide helpful?
Did you find out-of-date information?
Your plan denied your medication: the medical exception and its 48 hours
The Health Insurance Code gives the plan 48 hours to decide a medical exception, and guarantees your medication while it decides. 24 hours if controlled.
Surprise medical bill: what you can be charged out of network
In an emergency you cannot be billed above the copay, deductible or coinsurance that would apply in network. And there is arbitration if no deal is reached.
Your rights as a patient: what the Bill of Rights says
Act 194-2000 made plain: emergency access regardless of ability to pay, information before deciding, your medical record, and the right to appeal a denial.
Complaint to the Patient Advocate: health plan, hospital or provider
It covers insurers, mental health organisations and health service providers. It can be filed with a phone call.
How to apply for Plan Vital (Medicaid) in Puerto Rico
What Plan Vital is, why eligibility is determined by the Medicaid Program rather than ASES, what documents are requested, and how to pick an insurer.